Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/46621
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yakar, Fatih | - |
dc.contributor.author | Egemen, Emrah | - |
dc.contributor.author | Dere, Umit A. | - |
dc.contributor.author | Saginc, Halil | - |
dc.contributor.author | Gokdeniz, Ulas | - |
dc.contributor.author | Bakirarar, Batuhan | - |
dc.contributor.author | Gokdeniz, Ceyda G. | - |
dc.contributor.author | Baltalarli, Bahar | - |
dc.contributor.author | Coskun, Mehmet E. | - |
dc.contributor.author | Acar, Feridun | - |
dc.date.accessioned | 2023-01-09T21:15:32Z | - |
dc.date.available | 2023-01-09T21:15:32Z | - |
dc.date.issued | 2022 | - |
dc.identifier.issn | 0967-5868 | - |
dc.identifier.issn | 1532-2653 | - |
dc.identifier.uri | https://doi.org/10.1016/j.jocn.2021.12.015 | - |
dc.identifier.uri | https://hdl.handle.net/11499/46621 | - |
dc.description.abstract | High-grade gliomas (HGGs) are presently managed via surgical resection, external beam radiation therapy (EBRT), and chemotherapy. Although Gamma Knife radiosurgery (GKRS) is currently used to manage HGGs, it has not been considered standard care. This paper aims to compare the contribution of GKRS to clinical outcomes in patients in which gross total resection (GTR) cannot be achieved. We retrospectively reviewed the data of 99 patients with HGG (World Health Organization (WHO) grade III and IV) from two groups: group 1 consisted of 68 patients for which only EBRT was administered, and group 2 consisted of 31 patients for which EBRT and GKRS were administered. Patient demographic data, the extent of resection, IDH mutation, radiation dosage, progression-free survival (PFS), overall survival (OS), and follow-up time were recorded and compared across groups. The grade III/IV tumor ratio was 10/58 and 10/21 in groups 1 and 2, respectively. In group 2, PFS and OS were higher than in group 1 (P = 0.030 and 0.021). The mean follow-up time was 15.02 +/- 11.8 (3-52) and 18.9 +/- 98.6 (7-43) months in groups 1 and 2, respectively. In addition to the standard management of HGGs in patients without GTR, boost GKRS during the early postoperative period is beneficial for increasing PFS and OS. (c) 2021 Published by Elsevier Ltd. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Sci Ltd | en_US |
dc.relation.ispartof | Journal Of Clinical Neuroscience | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Glioblastoma | en_US |
dc.subject | Progression-free survival | en_US |
dc.subject | Radiosurgery | en_US |
dc.subject | Radiotherapy | en_US |
dc.subject | Central-Nervous-System | en_US |
dc.subject | Randomized Phase-Iii | en_US |
dc.subject | Stereotactic Radiosurgery | en_US |
dc.subject | Glioblastoma-Multiforme | en_US |
dc.subject | Adjuvant Temozolomide | en_US |
dc.subject | Malignant Gliomas | en_US |
dc.subject | Primary Brain | en_US |
dc.subject | Radiotherapy | en_US |
dc.subject | Survival | en_US |
dc.subject | Tumors | en_US |
dc.title | The effectiveness of gamma knife radiosurgery for the management of residual high-grade gliomas: A single institutional study | en_US |
dc.type | Article | en_US |
dc.identifier.volume | 95 | en_US |
dc.identifier.startpage | 159 | en_US |
dc.identifier.endpage | 163 | en_US |
dc.authorid | EGEMEN, Emrah/0000-0003-4930-4577 | - |
dc.authorid | DERE, Ümit Akın/0000-0002-6678-6224 | - |
dc.identifier.doi | 10.1016/j.jocn.2021.12.015 | - |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.authorscopusid | 57193483754 | - |
dc.authorscopusid | 55211014200 | - |
dc.authorscopusid | 57160389700 | - |
dc.authorscopusid | 57202403642 | - |
dc.authorscopusid | 57374721100 | - |
dc.authorscopusid | 57193121450 | - |
dc.authorscopusid | 57375035000 | - |
dc.authorwosid | EGEMEN, Emrah/I-2030-2017 | - |
dc.authorwosid | DERE, Ümit Akın/N-1435-2014 | - |
dc.authorwosid | Bakirarar, Batuhan/ACX-5602-2022 | - |
dc.identifier.pmid | 34929640 | en_US |
dc.identifier.scopus | 2-s2.0-85121284238 | en_US |
dc.identifier.wos | WOS:000754080600025 | en_US |
dc.identifier.scopusquality | Q2 | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.openairetype | Article | - |
item.cerifentitytype | Publications | - |
item.fulltext | No Fulltext | - |
item.grantfulltext | none | - |
item.languageiso639-1 | en | - |
crisitem.author.dept | 14.01. Surgical Medicine | - |
crisitem.author.dept | 14.01. Surgical Medicine | - |
crisitem.author.dept | 14.01. Surgical Medicine | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
crisitem.author.dept | 14.01. Surgical Medicine | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
crisitem.author.dept | 14.01. Surgical Medicine | - |
crisitem.author.dept | 14.01. Surgical Medicine | - |
Appears in Collections: | PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
CORE Recommender
SCOPUSTM
Citations
4
checked on Nov 16, 2024
WEB OF SCIENCETM
Citations
2
checked on Nov 21, 2024
Page view(s)
48
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.